Angiotensin II (Ang II), acting at Ang II type 1 (AT 1 ) receptors, increases the firing rate of neurons from Wistar-Kyoto (WKY) rat brain via protein kinase C (PKC)-and Calcium-calmodulin kinase II (CaMKII)-dependent mechanisms. The objectives of this study were two fold; first, to compare the Ang II-stimulated increase in firing of neurons from WKY and spontaneous hypertensive rats (SHR) and second, to elucidate the signaling mechanisms involved. Action potentials were measured in neurons cultured from SHR and WKY rat brains using the whole cell configuration of the patch clamp technique in the current clamp mode. Ang II (100 nM) caused 3-and 6-fold increases in neuronal firing rate in WKY rat and SHR neurons, respectively, effects that were abolished by the AT 1 R antagonist losartan (1 µM). Co-administration of calphostin C (10 µM, a PKC inhibitor) and KN-93 (10 µM, a CaMKII inhibitor) completely blocked this Ang II action in WKY rat neurons, while they caused only a 50% attenuation in SHR neurons. The residual increase in firing rate produced by Ang II in SHR neurons was blocked by inhibitors of phosphatidylinositol 3 kinase (PI3-kinase), either LY 294002 (10 µM) or wortmannin (100 nM). These observations suggest that a PI3-kinase signaling pathway may be responsible for the enhanced chronotropic effect produced by Ang II in SHR neurons.
INTRODUCTION
It is well established that the brain angiotensin system exerts regulatory influences in the control of blood pressure (BP) and thus plays a key role in the development and establishment of hypertension (Averill et supported by studies with the spontaneously hypertensive rat (SHR). These rats exhibit increased expression and activity of AT 1 R in a number of hypothalamic and brainstem regions such as the paraventricular nucleus, median preoptic nucleus, subfornical organ, nucleus tractus solitarius and dorsal motor nucleus of the vagus (Gehlert et al., 1986; Gutkind et al., 1988; Han and Sim, 1998; Lebrun et al. 1996; Lu et al. 1994 ; Raizada et al. 1999; Song et al., 1994) . In addition, interruption of brain AT 1 R function by pharmacological or genetic means lowers BP in the SHR (Lu et al. 1994 ). Despite these well-documented enhanced physiological actions of Ang II via brain AT 1 R in the SHR, the cellular and molecular basis of these effects remain poorly understood. We have developed an in vitro neuronal cell culture model from prehypertensive SHR to investigate the mechanisms of AT 1 R-mediated increases in Ang II actions in the SHR brain.
Studies from this model have established that increases in AT 1 R levels and Ang II-induced norepinephine neuromodulation observed in the adult SHR brain are preserved in vitro in neuronal cultures from pre-hypertensive rat brain. This has led us to propose that a hyperactive brain angiotensin system in the SHR is genetically linked and is not the result of an increase in BP (Lebrun et al. 1996) .
It is clear that the physiological response elicited by Ang II acting in the brain involve modulation of specific neuronal pathways ). This modulation includes rapid changes in neuronal activity, and our group has investigated the underlying cellular and intracellular events. These studies indicate that Ang II inhibits both delayed rectifier K + current (I Kv ) and transient (Atype) K + current (I A ) and stimulates total Ca 2+ current via the AT 1 R (Raizada et al.
1999
; Sumners et al. 2002) . These effects are consistent with our observation that Ang II elicits a positive chronotropic action involving PKC and CaMKII signaling pathways (Zhu et al. 1997; Wang et al. 1997 ).
Our objectives in the present study were two fold: 1) to investigate whether the effects of Ang II on neuronal firing rate are altered in SHR versus WKY rats, and 2) to delineate the signaling pathways linking the AT 1 R to neuronal activity in neurons from both strains. The rationale for these objectives was based on our previous observations that SHR neurons express higher levels of AT 1 R and exhibit increased norepinephrine neuromodulation compared to WKY rat neurons (Lu et al. 1994 ). 
METHODS

Materials and animals:
Data analysis:
Results are expressed as means ± SE. Statistical significance was evaluated with the use of a 1-way ANOVA followed by a Newman-keuls test.
Differences were considered significant at P<0.05.
RESULTS
Chronotropic effects of Ang II in SHR and WKY rat neurons.
Spontaneous action potentials (APS) recorded from either SHR or WKY rat neurons exhibited similar electrophysiological properties. In addition, these
properties were similar to those observed in Sprague-Dawley (SD) rat neurons, another normotensive control (11) . For example, the mean amplitude and time to elicited increases in firing rate in both WKY rat and SHR neurons, effects that were concentration-dependent. For example, in WKY rat neurons, superfusion of 10 nM and 100 nM Ang II produced increases in firing rate of 97 ± 17% (n=4) and 324 ± 65% (n=10) respectively. By contrast, in SHR neurons, the effects of Ang II were significantly greater. Superfusion of 10 nM and 100 nM Ang II produced respective increases in firing rate of 268 ± 45% (n=4) and 556 ± 64% (n=10).
The data for 100nM Ang II are presented in Figure 1 . Furthermore, the chronotropic actions of Ang II in both rat strains were abolished by 1 µM losartan, an AT 1 R selective antagonist ( Figure 1 ). Losartan alone did not alter the firing rate of SHR or WKY rat neurons (data not shown).
Effects of PKC and CaMKII inhibitors on the chronotropic response to Ang II in SHR and WKY rat neurons:
Our recent studies have demonstrated that the chronotropic effects of Ang II via AT 1 R are mediated by activation of PKC and CaMKII in neurons from normotensive (SD and WKY) rats . Here, we have used a pharmacological strategy to determine whether PKC-and CaMKII -dependent mechanisms are also responsible for the chronotropic response produced by Ang II in SHR neurons. 
Effect of PI3-kinase inhibitors on the chronotropic effects of Ang II:
Our previous studies have established that Ang II stimulates PI3-kinase in both WKY and SHR neurons (Yang et al. 1996; . While the role of PI3-kinase in the modulation of neuronal activity is not known, it mediates the neuritogenic effect of Ang II in WKY rat neurons . These observations led us to hypothesize that the chronotropic action of Ang II in SHR neurons that is not inhibited by calphostin C and KN-93 may involve PI3-kinase.
Thus, the role of PI3-kinase in the Ang II-induced increase in firing rate in SHR and WKY rat neurons was examined using the PI3-kinase inhibitors, LY294002
(10 µM) and wortmannin (100 nM). Figure 3 demonstrates that superfusion of SHR and WKY rat neuronal cultures with Ang II (100 nM) in the presence of 1 µM PD 123,319 produced the expected increases in firing rate, and that superfusion of these cells with 10 µM LY294002 did not significantly alter basal firing rate.
The data also demonstrates that while LY 294002 did not affect the Ang IIinduced chronotropic effect in WKY rat neurons, it significantly blunted this Ang II action in SHR neurons (Figure 3) . In fact this PI3-kinase inhibitor reduced the Ang II-induced chronotropic effect in SHR neurons to the level seen in WKY rat neurons ( Figure 3 ). Similar data were obtained when using a different PI3-kinase inhibitor, wortmannin (100 nM). This agent reduced the chronotropic action of Ang II in SHR neurons, but had no significant effects in WKY rat neurons (data not shown).
Ang II-induced increases in firing rate in SHR neurons are abolished by co-incubation with CaMKII-, PKC-and PI3-kinase inhibitors:
In the next series of experiments, we examined the effect of simultaneous incubation of neurons with PI3-kinase, PKC, and CaMKII inhibitors on the chronotropic effect induced by Ang II in SHR neurons. Figure 4 shows that Ang II (100 nM) triggered a significant increase in firing rate in SHR neurons. This effect was completely abolished by the combined superfusion of calphostin C (10 µM), KN-93 (10 µM), and LY294002 (10 µM). This further suggests that PI3-kinasedependent signaling may be responsible for the enhanced chronotropic response to this peptide in SHR neurons.
DISCUSSION
The most significant finding in the present study is that the enhanced chronotropic effect of Ang II in SHR neurons is blocked by inhibition of PI3
kinase. This suggests that PI3 kinase may be exclusively involved in the chronotropic actions of Ang II. The diagram in Figure 5 This hypothesis is primarily based on the use of pharmacoglogical agents to inhibit these kinases and we must use some caution in interpretation of this data.
Further evidence with the use of PI3 kinase dominant negative mutants will be needed to confirm these ideas.
Our previous studies have established that the expression of AT 1 R is 2 -4 fold higher in neuronal cultures for SHR hypothalamus/brainstem compared with equivalent cultures from normotensive (WKY, and SD) rats (6, 7) . Consistent with this is a parallel increase in Ang II's transcriptionally-regulated neuromodulatory effects in SHR neurons, involving a Ras-MAP kinase signaling pathway (Lu et al. 1998; Yang et al. 1996) . These and other studies have established that the additional increase of AT 1 receptor-mediated neuromodulation is linked to the genetics of hypertension rather than being a consequence of the increase in BP, since the neurons are prepared from prehypertensive SHR ). 
